January 19, 2021:
Nilesh Patel Joins Cellanyx Board of Directors
—
February 21, 2019:
Cellanyx Publication Chosen As Cover of the February Edition of the Journal Urology.
—
December 13, 2018:
Cellanyx CEO Interviewed for 360Dx Article Covering Cellanyx’s Latest Publication.
—
November 30, 2018:
Oncozine Highlights Cellanyx’s Proof-of-Concept Results.
—
November 22, 2018:
Cellanyx Reports Results of Biomarker Test For Prostate Cancer.
—
November 21, 2018:
—
November 15, 2018:
BioWorld Covers Cellanyx’s Recent Publication and Key Progress.
—
October 31, 2018:
Urology Times Reports on Cellanyx’s Nature Biomedical Engineering Paper and Key Results.
—
October 10, 2018:
Science Translational Medicine Editors Cover Cellanyx’s Risk Stratification Technology.
—
September 18, 2018:
360Dx Highlights Cellanyx’s Live Tumor Cell Phenomics Platform.
—
September 17, 2018:
Biospace Covers Cellanyx’s Phenomics Analysis Platform.
—
September 17, 2018:
Cellanyx’s Live-Cell-Analytics Platform Covered by Digital Journal.
—
September 17, 2018:
Business Journals Underscores Cellanyx’s Recent Technological Progress.
—
September 17, 2018:
—
August 5, 2018:
Dr. David Albala presents Cellanyx’s Phenotypic & Machine Learning Platform Data to Key Opinion Leaders in Prostate Cancer at the Third Global Summit on Precision Diagnosis for Prostate Cancer.
—
September 12, 2017:
Cellanyx wins 1st place poster award at 2nd International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology.
—
August 2, 2017:
—
July 21, 2017:
—
July 21, 2017:
—
July 21, 2017:
Cellanyx takes first place at the Medstartr pitch contest during San Diego Startup Week, 2017.
—
July 20, 2017:
Cellanyx one of two Massachusetts companies to present at Startup Stadium at the annual BIO, 2017.
—
July 19, 2017:
Cellanyx one of 45 companies to present at 2017 International Cancer Cluster Showcase at BIO, 2017.
—
July 1, 2017:
Cellanyx places third in annual MALSI day poster competition.
—
June 1, 2017:
Cellanyx featured in Biospace highlighting breakthrough in culturing primary prostate biopsy cells.
—
June 1, 2017:
In the Journal Urology, Cellanyx reports novel method to culture Primary Prostate Biopsy Cells.
—
May 12, 2017:
Cellanyx scheduled to present this June at BIO International Convention 2017 Start-Up Stadium.
—
March 31, 2017:
—
September 28, 2016:
—
June 1, 2016:
—
July 23, 2015:
Recent Press Highlights Cellanyx’s Progress
Wall Street Journal: Daily Startup Blog
Dow Jones Private Equity & Venture Capital News Portal
—
February 20, 2015:
Link to Poster
—
January 26, 2015:
Cellanyx gaining traction through startup competition success
—
July 24, 2014:
Cellanyx CEO on establishing operations in Boston
—
November 12, 2013:
Cellanyx announces Series A1 Funding Round
—
July 12, 2013:
Cellanyx joins StartX Mentor Labs
—
July 1, 2013:
Cellanyx welcomes Dr. David Albala and Dr. Catherine Fink to its Senior Advisory Board.
—
June 4, 2013:
Cellanyx named semifinalist at Founder.org competition
—
June 1, 2013:
Cellanyx welcomes Dr. Kevin Knopf to its Senior Advisory Board.
—
May 17, 2013:
Cellanyx CEO Ashok Chander interviewed for Boston Business Journal
—
May 1, 2013:
Cellanyx named semifinalist at Berkeley Venture Lab competition
—
May 1, 2013:
Cellanyx welcomes Ms. Ann Whittaker to its Senior Advisory Board.
—
April 26, 2013:
Cellanyx welcomes Mr. Imran Nasrullah to its Senior Advisory Board.
—
April 10, 2013:
Cellanyx wins M2D2 Venture Competition
—
April 9, 2013:
Cellanyx presents at Merck’s Early-Stage Life Sciences Technology Conference
—
April 4, 2013:
Cellanyx wins Boston University’s New Venture Competition
—
March 15, 2013:
Cellanyx welcomes Dr. Samuel Sia to its Senior Advisory Board.
—
March 1, 2013:
Cellanyx welcomes Dr. Una Ryan and Dr. Edward R. Berger to its Senior Advisory Board.
—
February 15, 2013:
Cellanyx welcomes Mr. Peter Parker to its Senior Advisory Board.
—
February 1, 2013:
Cellanyx welcomes Dr. Colin Brenan, Dr. Pamela Avallone, and Dr. Pravin Chaturvedi to its Senior Advisory Board.
—
January 17, 2013:
—
January 8, 2013:
Cellanyx welcomes Mr. Amar Kendale and Dr. Satish Tadikonda to its Senior Advisory Board.